Biomarin Pharmaceutical Inc Liquidation Value
BMRN
Other
Cash & Equivalents
$1.31B
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
N/A
Liquid Liquidation Value
Cash + AR minus Total Obligations
N/A
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
N/A
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | N/A | N/A |
| Liquid Liquidation Value | N/A | N/A |
| Operating Liquidation Value | N/A | N/A |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $1.31B |
| Accounts Receivable | $908.21M |
| Inventory | $1.30B |
| Current Liabilities | $759.03M |
| Long-term Debt | $600.00M |
| Op. Lease Liability | $45.15M |
| Finance Lease | $552,000 |
| Shares Outstanding | 192.3M |
Explore all 248 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $1.31B | $908.21M | $1.30B | N/A | $759.03M | $600.00M | $45.15M | $552,000 |
| 2025-09-30 | $1.25B | $790.27M | $1.38B | N/A | $798.44M | $600.00M | N/A | N/A |
| 2025-06-30 | $1.21B | $855.86M | $1.34B | N/A | $684.25M | $600.00M | N/A | N/A |
| 2025-03-31 | $1.05B | $739.18M | $1.27B | N/A | $628.21M | $600.00M | N/A | N/A |
| 2024-12-31 | $942.84M | $660.53M | $1.23B | N/A | $606.99M | $600.00M | $37.73M | $1.10M |
| 2024-09-30 | $675.45M | $777.55M | $1.18B | N/A | $715.66M | $600.00M | N/A | N/A |
| 2024-06-30 | $972.15M | $691.23M | $1.18B | N/A | $1.07B | $1.10B | N/A | N/A |
| 2024-03-31 | $747.00M | $637.16M | $1.14B | N/A | $1.09B | $1.10B | N/A | N/A |
▼ Community Notes